Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas

Floryne O. Buishand, Ger J. A. Arkesteijn, Laurien R. Feenstra, Claire W. D. Oorsprong, Margiet Mestemaker, Achim Starke, Ernst-Jan M. Speel, Jolle Kirpensteijn, Jan A. Mol

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)826-835
JournalStem Cells and Development
Volume25
Issue number11
DOIs
Publication statusPublished - 1 Jun 2016

Cite this

Buishand, F. O., Arkesteijn, G. J. A., Feenstra, L. R., Oorsprong, C. W. D., Mestemaker, M., Starke, A., ... Mol, J. A. (2016). Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas. Stem Cells and Development, 25(11), 826-835. https://doi.org/10.1089/scd.2016.0032
Buishand, Floryne O. ; Arkesteijn, Ger J. A. ; Feenstra, Laurien R. ; Oorsprong, Claire W. D. ; Mestemaker, Margiet ; Starke, Achim ; Speel, Ernst-Jan M. ; Kirpensteijn, Jolle ; Mol, Jan A. / Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas. In: Stem Cells and Development. 2016 ; Vol. 25, No. 11. pp. 826-835.
@article{7ac9c9e7dfbc4121be2a1bac52fa2088,
title = "Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas",
author = "Buishand, {Floryne O.} and Arkesteijn, {Ger J. A.} and Feenstra, {Laurien R.} and Oorsprong, {Claire W. D.} and Margiet Mestemaker and Achim Starke and Speel, {Ernst-Jan M.} and Jolle Kirpensteijn and Mol, {Jan A.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1089/scd.2016.0032",
language = "English",
volume = "25",
pages = "826--835",
journal = "Stem Cells and Development",
issn = "1547-3287",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

Buishand, FO, Arkesteijn, GJA, Feenstra, LR, Oorsprong, CWD, Mestemaker, M, Starke, A, Speel, E-JM, Kirpensteijn, J & Mol, JA 2016, 'Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas', Stem Cells and Development, vol. 25, no. 11, pp. 826-835. https://doi.org/10.1089/scd.2016.0032

Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas. / Buishand, Floryne O.; Arkesteijn, Ger J. A.; Feenstra, Laurien R.; Oorsprong, Claire W. D.; Mestemaker, Margiet; Starke, Achim; Speel, Ernst-Jan M.; Kirpensteijn, Jolle; Mol, Jan A.

In: Stem Cells and Development, Vol. 25, No. 11, 01.06.2016, p. 826-835.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas

AU - Buishand, Floryne O.

AU - Arkesteijn, Ger J. A.

AU - Feenstra, Laurien R.

AU - Oorsprong, Claire W. D.

AU - Mestemaker, Margiet

AU - Starke, Achim

AU - Speel, Ernst-Jan M.

AU - Kirpensteijn, Jolle

AU - Mol, Jan A.

PY - 2016/6/1

Y1 - 2016/6/1

U2 - 10.1089/scd.2016.0032

DO - 10.1089/scd.2016.0032

M3 - Article

VL - 25

SP - 826

EP - 835

JO - Stem Cells and Development

JF - Stem Cells and Development

SN - 1547-3287

IS - 11

ER -

Buishand FO, Arkesteijn GJA, Feenstra LR, Oorsprong CWD, Mestemaker M, Starke A et al. Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas. Stem Cells and Development. 2016 Jun 1;25(11):826-835. https://doi.org/10.1089/scd.2016.0032